RAS Life Science Solutions retweeted
See the long-term (lifetime) effects of dapagliflozin in chronic kidney disease: a time-to-event analysis academic.oup.com/ndt/article… @Stenodiabetes @NDTsocial
6th epi of #KnowYourTrial series! Explore the latest assets in #clinicaldevelopment, therapy areas, and #drug classes. Our KYT series highlights pros transitioning from molecule discovery to human #clinicaltrials in Sep 2023. Stay tuned for #pharmaceuticalindustry insights!
🌟September is Ovarian Cancer Awareness Month 🌟
Let's come together this September to amplify the message of ovarian cancer awareness.
Watch this video to learn more.... #ovariancancer #oncology #CancerResearch #raslss
We are attending #PARISNASH, follow for more updates
linkedin.com/feed/update/urn…
#NASH #NAFLD #liver #steatosis #inflammation #ballooning #fibrosis #PARISNASH
However, gaps still exist. Inga Drossart at #esc2023 presented a complex yet comprehensive picture of the #digitaldivide that still exists with #design and #interoperability as two major issues (among others) that adversely affect the uptake of devices in healthcare
Some hard evidence of the utility of #wearables was presented by Prof. Svennberg in her #digitalhealth talk at #esc2023. The studies are small but the meta-analysis gives us a positive indicator that the #wearables do encourage physical activity.
There are multiple opportunities for digital technologies to improve #patientcare. Prof. Svennberg summarized it succinctly in a single diagram in a #digitalhealth talk at #esc2023
A fascinating lecture by Prof. Hae-Young Lee on CART ring device for continuous non-intrusive BP monitoring, at #ESC2023. This device might just open a new area of research Dynamic BP monitoring for superior CV risk prediction and treatment optimization.
The ability to measure BP, by the minute will open up immense avenues of research on patient risk stratification and possibly catching asymptomatic individuals much before it’s too late! #ESC2023
Another exciting session of #digitalhealth at #ESC2023 - a quick history of #bpmonitoring…what a long way we have come from the first sphygmomanometer in 1830s to cuffless connected wearables of today
#DigitalMedicine at its best at #esc2023. We will be posting a #digitalhealth series in the coming few days.
For starters - a smartphone based #heartmurmur screening device.
Hello from Amsterdam! We are attending the #esc2023 congress, one of largest cardiology conference that showcases innovation and latest research in cardiology. Follow us for all the live updates #cardiologyconference #cardiology #conference2023 #raslss #digitalhealth
We have done it..... Chandrayaan-3 has landed on the moon. Well done India.. well done ISRO...
Hello Moon
#ISRO #Chandrayaan3
We are excited to share some of the key highlights from ASCO 2023. This year's conference showcased groundbreaking research, innovative therapies, and collaborative efforts aimed at advancing cancer care. #asco23 #immunotherapy #CancerResearch #precisionmedicine #oncologytrials
Sharing the 5th episode of our monthly #KnowYourTrial series, where we provide the therapy area distribution and key drug classes of the assets entering #clinicaldevelopment in May 2023. Follow us for more
We are back with the 4th episode of the #KnowYourTrial series, where we give you #insights on the de novo assets that have entered #clinicaldevelopment in the US #clinicaltrial registry. Check out the therapy area and key drug class distribution in April 2023. Stay tuned for more
Are you familiar with #Oman's #pharmaceutical market? Get insights on #branded vs #generic distribution, local #manufacturing vs #imports, major #therapyareas, top companies, #healthcare spending, and more. Follow #KYM series & #RASLSSconsulting for pdf
linkedin.com/feed/update/urn…
#Didyouknow, May is #bladdercancer awareness month? In the US alone, there are ~82,290 new cases and ~16,710 deaths annually. Treatment depends on the stage of the #cancer . Early detection/treatment are crucial for better outcomes. Check out our video to know more #raslss #DYK


















